Canadian OTC private label and Rx generics giant Apotex has agreed to be acquired by private investment firm SK Capital Partners, which promises to support its "next phase of growth and continued innovation for patient affordability.”
Announcing the deal on 28 September, SK said an affiliate of funds has reached an agreement to acquire Apotex Pharmaceutical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?